$1.85
0.010.54%
Últ. Act.: Nov 6, 5:20 PM
Fortress Biotech (FBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.08 | $-0.20 | 60.0 % |
| Q1 | May 14, 2026 | $2.82 | $-0.08 | 3625.0 % |
| Q4 | Mar 31, 2026 | $-0.30 | $0.23 | -230.4 % |
| Q3 | Nov 14, 2025 | $0.11 | $-0.55 | 120.0 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $18.72M | $18.30M | 2.28 % |
| Q1 | May 14, 2026 | $16.04M | $16.34M | -1.84 % |
| Q4 | Mar 31, 2026 | $16.08M | $29.12M | -44.8 % |
| Q3 | Nov 14, 2025 | $17.63M | $22.08M | -20.2 % |
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.08 | $0.23 | $-0.55 |
| Actual | $-0.08 | $2.82 | $-0.30 | $0.11 |
| Surprise | +60.0% | +3625.0% | -230.4% | +120.0% |
| Revenue | ||||
| Estimate | $18.3M | $16.3M | $29.1M | $22.1M |
| Actual | $18.7M | $16.0M | $16.1M | $17.6M |
| Surprise | +2.28% | -1.84% | -44.8% | -20.2% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.27 | $-0.25 |
| Revenue | ||
| Consensus | $21.6M | $22.5M |